Showing 131-140 of 3305 results for "".
- Fractional CO₂ Laser-Assisted Methotrexate Rivals 5-FU in Stable Vitiligohttps://modernaesthetics.com/news/fractional-co-laser-assisted-methotrexate-rivals-5-fu-in-stable-vitiligo/2487990/Topical methotrexate (MTX) delivered through fractional CO₂ laser (FCL) demonstrated efficacy and safety comparable to laser-assisted 5-fluorouracil (5-FU) for stable, nonsegmental vitiligo, according to a study published in Derm
- Meta-Analysis: Comparable Overall Outcomes With Lasers and Chemical Peels for Skin Rejuvenationhttps://modernaesthetics.com/news/meta-analysis-vcomparable-overall-outcomes-with-lasers-and-chemical-peels-for-skin-rejuvenation/2487992/A systematic review and meta-analysis published in Plastic and Reconstructive Surgery found that laser resurfacing and chemical peeling provide comparable overall efficacy for skin rejuvenation, although each modality demon
- Secondary Liquid Rhinoplasty Achieves 90%+ Patient Satisfaction: Studyhttps://modernaesthetics.com/news/secondary-liquid-rhinoplasty-achieves-90-patient-satisfaction-study/2487989/Secondary liquid rhinoplasty using hyaluronic acid dermal fillers may offer a safe and effective option for correcting postsurgical nasal contour irregularities, according to a large retrospective study published in the Aesthetic
- Allergan Aesthetics Announces Return of JUVÉDERM® Day for 2026https://modernaesthetics.com/news/allergan-aesthetics-announces-return-of-juvederm-day-for-2026/2487978/Allergan Aesthetics, an AbbVie company, has announced that JUVÉDERM® Day will return to the United States on August 19, 2026. The annual event will coincide with the 20th anniversary of the brand's first US Food and Drug Administration (FDA) approval and will feature promotional offers for member
- Non-Light-Based Energy Devices Continue to Expand the Aesthetic Treatment Landscapehttps://modernaesthetics.com/news/non-light-based-energy-devices-continue-to-expand-the-aesthetic-treatment-landscape/2487934/A growing body of evidence supports the use of non-light-based energy devices as minimally invasive treatment options for a wide range of aesthetic concerns, according to a newly published review in the Journal of Craniofacial Surgery. The review summarizes current evidence surrounding r
- Swiss Skincare Brand Launches Personalized Art of Longevity Programhttps://modernaesthetics.com/news/swiss-skincare-brand-launches-personalized-art-of-longevity-program/2487890/Swiss skincare company Valmont has introduced The Art of Longevity, a personalized program designed to integrate genetic analysis, lifestyle assessment, and professional skincare into an individualized longevity strategy. According to the company, the initiative was developed by Valmont CE
- Merz Aesthetics Brings Back Original NEOCUTIS Journée Formulahttps://modernaesthetics.com/news/merz-aesthetics-brings-back-original-neocutis-journee-formula/2487865/Merz Aesthetics has reintroduced NEOCUTIS Journée Revitalizing Day Cream SPF 30, bringing back the original formulation of the company's multifunctional daytime moisturizer after previously discontinuing the Journée Firm line. According to the company, the product returns in response to fe
- Allergan Aesthetics Invests in SkinMedica's Regenerative Science Strategyhttps://modernaesthetics.com/news/allergan-aesthetics-invests-in-skinmedicas-regenerative-science-strategy/2487856/Allergan Aesthetics, an AbbVie company, announced a series of initiatives aimed at expanding SkinMedica's regenerative science platform, including the formation of a Regenerative Science Advisory Board, the expansion of its research and development laboratory, and the launch of physician-based fl
- American Pharmacists Association Urges FDA to Put Patient Safety First in Peptide Reviewhttps://modernaesthetics.com/news/apha-urges-fda-to-put-patient-safety-first-in-peptide-review/2487836/The American Pharmacists Association (APhA) is urging the US Food and Drug Administration (FDA) to prioritize patient safety, scientific evidence, and regulatory oversight in its decision-making process, according to
- Study Links Non-Ablative Fractional Laser Treatment to Epigenetic Remodeling of Aging Skinhttps://modernaesthetics.com/news/study-links-non-ablative-fractional-laser-treatment-to-epigenetic-remodeling-of-aging-skin/2487808/A new study published in Scientific Reports provides in vivo human evidence that treatment with a 1940-nm non-ablative fractional laser may induce durable epigenetic changes associated with skin rejuvenation, expanding understanding of the biologic effects of energy-based devices beyond